Literature DB >> 2039493

Primary hyperoxaluria type I due to a point mutation of T to C in the coding region of the serine:pyruvate aminotransferase gene.

K Nishiyama1, T Funai, R Katafuchi, F Hattori, K Onoyama, A Ichiyama.   

Abstract

cDNA clones for serine:pyruvate aminotransferase (SPT, alternative name: alanine:glyoxylate aminotransferase) were obtained from a cDNA library constructed from the liver of a primary hyperoxaluria type I (PH1) case in which the SPT activity was approximately one-hundredth that in control liver. Six clones were isolated from 100,000 transformants and all of them contained an approximately 1.5 kbp insert which included the whole coding region for human SPT. Nucleotide sequence analysis revealed a point mutation of T to C at position 634 (relative to the 5'-end of the cDNA) encoding a Ser to Pro substitution at residue 205. The T to C conversion created a new SmaI site, which enabled us to demonstrate that the point mutation had occurred in the patient's SPT gene. SmaI digestion of genomic DNA may be useful for the diagnostic gene analysis of this type of PH1.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2039493     DOI: 10.1016/0006-291x(91)90396-o

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Primary hyperoxaluria type 1: diagnostic relevance of mutations and polymorphisms in the alanine:glyoxylate aminotransferase gene (AGXT).

Authors:  A C Tarn; C von Schnakenburg; G Rumsby
Journal:  J Inherit Metab Dis       Date:  1997-09       Impact factor: 4.982

Review 2.  The genetic components of idiopathic nephrolithiasis.

Authors:  Massimo Attanasio
Journal:  Pediatr Nephrol       Date:  2010-06-19       Impact factor: 3.714

3.  Molecular characterization and clinical use of a polymorphic tandem repeat in an intron of the human alanine:glyoxylate aminotransferase gene.

Authors:  C J Danpure; G M Birdsey; G Rumsby; M J Lumb; P E Purdue; J Allsop
Journal:  Hum Genet       Date:  1994-07       Impact factor: 4.132

Review 4.  Primary hyperoxaluria type 1: genotypic and phenotypic heterogeneity.

Authors:  C J Danpure; P R Jennings; P Fryer; P E Purdue; J Allsop
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

5.  Enzymological and mutational analysis of a complex primary hyperoxaluria type 1 phenotype involving alanine:glyoxylate aminotransferase peroxisome-to-mitochondrion mistargeting and intraperoxisomal aggregation.

Authors:  C J Danpure; P E Purdue; P Fryer; S Griffiths; J Allsop; M J Lumb; K M Guttridge; P R Jennings; J I Scheinman; S M Mauer
Journal:  Am J Hum Genet       Date:  1993-08       Impact factor: 11.025

6.  In vivo and in vitro examination of stability of primary hyperoxaluria-associated human alanine:glyoxylate aminotransferase.

Authors:  Erin D Hopper; Adrianne M C Pittman; Michael C Fitzgerald; Chandra L Tucker
Journal:  J Biol Chem       Date:  2008-09-09       Impact factor: 5.157

7.  A novel mutation of human liver alanine:glyoxylate aminotransferase causes primary hyperoxaluria type 1: immunohistochemical quantification and subcellular distribution.

Authors:  Chikage Kawai; Yohsuke Minatogawa; Hidetaka Akiyoshi; Shinichi Hirose; Tsunatoshi Suehiro; Shigenobu Tone
Journal:  Acta Histochem Cytochem       Date:  2012-03-10       Impact factor: 1.938

8.  Laboratory diagnosis of disorders of peroxisomal biogenesis and function: a technical standard of the American College of Medical Genetics and Genomics (ACMG).

Authors:  Irene De Biase; Silvia Tortorelli; Lisa Kratz; Steven J Steinberg; Kristina Cusmano-Ozog; Nancy Braverman
Journal:  Genet Med       Date:  2019-12-11       Impact factor: 8.822

9.  ATP-dependent degradation of a mutant serine: pyruvate/alanine:glyoxylate aminotransferase in a primary hyperoxaluria type 1 case.

Authors:  K Nishiyama; T Funai; S Yokota; A Ichiyama
Journal:  J Cell Biol       Date:  1993-12       Impact factor: 10.539

10.  Mutational analysis of AGXT in two Chinese families with primary hyperoxaluria type 1.

Authors:  Guo-min Li; Hong Xu; Qian Shen; Yi-nv Gong; Xiao-yan Fang; Li Sun; Hai-mei Liu; Yu An
Journal:  BMC Nephrol       Date:  2014-06-17       Impact factor: 2.388

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.